{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:15:44Z","timestamp":1787166944133,"version":"build-2736575974"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Biochemistry and Biophysics"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.abb.2025.110470","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T19:08:13Z","timestamp":1747422493000},"page":"110470","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Mechanism of flavonoid myricetin modulated aggregation in \u03b1-Synuclein and its familial mutants E46K and A30P"],"prefix":"10.1016","volume":"770","author":[{"family":"Tinku","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anitadevi K.","family":"Prajapati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satrujeet","family":"Sahoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Deepak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumya","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1679-8099","authenticated-orcid":false,"given":"Sinjan","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.abb.2025.110470_bib1","series-title":"Parkinson's Disease: Pathogenesis and Clinical Aspects","article-title":"The differential diagnosis of Parkinson's disease","author":"Greenland","year":"2018"},{"key":"10.1016\/j.abb.2025.110470_bib2","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1055\/s-2007-985336","article-title":"Differentiating Parkinson's disease from other parkinsonian disorders","volume":"27","author":"Alvarez","year":"2007","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.abb.2025.110470_bib3","article-title":"Parkinson's disease as a system-level disorder","volume":"2","author":"Caligiore","year":"2016","journal-title":"npj Parkinson's Dis."},{"key":"10.1016\/j.abb.2025.110470_bib4","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1440-1789.2007.00803.x","article-title":"The Lewy body in Parkinson's disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates","volume":"27","author":"Wakabayashi","year":"2007","journal-title":"Neuropathology"},{"key":"10.1016\/j.abb.2025.110470_bib5","series-title":"Textbook of Clinical Neurology","first-page":"699","article-title":"The degenerative dementias","author":"Caselli","year":"2007"},{"issue":"2","key":"10.1016\/j.abb.2025.110470_bib6","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009399","article-title":"\u03b1-Synuclein in Parkinson's disease","volume":"2","author":"Stefanis","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.abb.2025.110470_bib7","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1371\/journal.pbio.0060006","article-title":"Conformational equilibria in monomeric alpha-synuclein at the single-molecule level","volume":"6","author":"Sandal","year":"2008","journal-title":"PLoS Biol."},{"key":"10.1016\/j.abb.2025.110470_bib8","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3233\/JPD-150642","article-title":"The synaptic function of \u03b1-synuclein","volume":"5","author":"Burr\u00e9","year":"2015","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.abb.2025.110470_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.1081426","article-title":"The role of the endolysosomal pathway in \u03b1-Synuclein pathogenesis in Parkinson's disease","volume":"16","author":"Smith","year":"2023","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.abb.2025.110470_bib10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4103\/1735-1995.181989","article-title":"Alpha-synuclein structure, functions, and interactions","volume":"21","author":"Emamzadeh","year":"2016","journal-title":"J. Res. Med. Sci."},{"key":"10.1016\/j.abb.2025.110470_bib11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13024-019-0329-1","article-title":"Alpha-synuclein structure and Parkinson's disease \u2013 lessons and emerging principles","volume":"14","author":"Meade","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.abb.2025.110470_bib12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41531-021-00203-9","article-title":"Alpha-synuclein research: defining strategic moves in the battle against Parkinson's disease","volume":"7","author":"Oliveira","year":"2021","journal-title":"npj Parkinson's Dis."},{"key":"10.1016\/j.abb.2025.110470_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1120416","article-title":"Amyloid oligomers as on-pathway precursors or off-pathway competitors of fibrils","volume":"10","author":"Muschol","year":"2023","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.abb.2025.110470_bib14","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3390\/ijms25010360","article-title":"Alpha-synuclein contribution to neuronal and glial damage in Parkinson's disease","volume":"25","author":"Saramowicz","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.abb.2025.110470_bib15","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1038\/s41467-021-21937-3","article-title":"The release of toxic oligomers from \u03b1-Synuclein fibrils induces dysfunction in neuronal cells","volume":"12","author":"Cascella","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.abb.2025.110470_bib16","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.4103\/1673-5374.371345","article-title":"\u03b1-Synuclein oligomers and fibrils: partners in crime in synucleinopathies","volume":"18","author":"Bigi","year":"2023","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.abb.2025.110470_bib17","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.biopha.2018.12.101","article-title":"Emerging pathways to neurodegeneration: dissecting the critical molecular mechanisms in Alzheimer's disease, Parkinson's disease","volume":"111","author":"Tan","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"43","key":"10.1016\/j.abb.2025.110470_bib18","doi-asserted-by":"crossref","first-page":"15227","DOI":"10.1523\/JNEUROSCI.3545-12.2012","article-title":"Systematic mutagenesis of \u03b1-synuclein reveals distinct sequence requirements for physiological and pathological activities","volume":"32","author":"Burr\u00e9","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.abb.2025.110470_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-95889-5","article-title":"Studying the effect of alpha-synuclein and Parkinson's disease linked mutants on inter pathway connectivities","volume":"11","author":"Sen","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.abb.2025.110470_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/srep24475","article-title":"The Parkinson Disease gene SNCA: evolutionary and structural insights with pathological implication","volume":"6","author":"Siddiqui","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.abb.2025.110470_bib21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neulet.2013.04.058","article-title":"\u03b1-Synuclein mutations cluster around a putative protein loop","volume":"546","author":"Kara","year":"2013","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.abb.2025.110470_bib22","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s42003-019-0598-9","article-title":"Alpha-synuclein stepwise aggregation reveals features of an early onset mutation in Parkinson's disease","volume":"2","author":"de Oliveira","year":"2019","journal-title":"Commun. Biol."},{"key":"10.1016\/j.abb.2025.110470_bib23","doi-asserted-by":"crossref","first-page":"6770","DOI":"10.1038\/s41598-022-10789-6","article-title":"Mechanisms of enhanced aggregation and fibril formation of Parkinson's disease-related variants of \u03b1-Synuclein","volume":"12","author":"Ohgita","year":"2022","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.abb.2025.110470_bib24","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ana.10795","article-title":"The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia","volume":"55","author":"Zarranz","year":"2004","journal-title":"Ann. Neurol."},{"issue":"37","key":"10.1016\/j.abb.2025.110470_bib25","doi-asserted-by":"crossref","first-page":"10328","DOI":"10.1073\/pnas.1604645113","article-title":"Mutations associated with familial Parkinson's disease alter the initiation and amplification steps of \u03b1-synuclein aggregation","volume":"113","author":"Flagmeier","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.abb.2025.110470_bib26","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/jnc.13750","article-title":"Current and experimental treatments of Parkinson disease: a guide for neuroscientists","volume":"139","author":"Oertel","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.abb.2025.110470_bib27","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.25634.1","article-title":"Recent developments in the treatment of Parkinson's Disease","volume":"9","author":"Stoker","year":"2020","journal-title":"F1000Research"},{"key":"10.1016\/j.abb.2025.110470_bib28","doi-asserted-by":"crossref","first-page":"770","DOI":"10.3390\/pharmaceutics15030770","article-title":"Current treatments and new, tentative therapies for Parkinson's disease","volume":"15","author":"Pardo-Moreno","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.abb.2025.110470_bib29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s10020-021-00279-2","article-title":"Novel targeted therapies for Parkinson's disease","volume":"27","author":"Ntetsika","year":"2021","journal-title":"Mol. Med."},{"key":"10.1016\/j.abb.2025.110470_bib30","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1017\/jns.2016.41","article-title":"Flavonoids: an overview","volume":"5","author":"Panche","year":"2016","journal-title":"J. Nutr. Sci."},{"key":"10.1016\/j.abb.2025.110470_bib31","doi-asserted-by":"crossref","first-page":"5243","DOI":"10.3390\/molecules25225243","article-title":"Important flavonoids and their role as a therapeutic agent","volume":"25","author":"Ullah","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.abb.2025.110470_bib32","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/08923973.2021.1916525","article-title":"Protective effect of myricetin, apigenin, and hesperidin pretreatments on cyclophosphamide\u2010induced immunosuppression","volume":"43","author":"Berk\u00f6z","year":"2021","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.abb.2025.110470_bib33","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.21873\/anticanres.11502","article-title":"Myricetin induces apoptosis of human anaplastic thyroid cancer cells via mitochondria dysfunction","volume":"37","author":"Jo","year":"2017","journal-title":"Anticancer Res."},{"key":"10.1016\/j.abb.2025.110470_bib34","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1096\/fj.201601339R","article-title":"Myricetin: a potent approach for the treatment of type 2 diabetes as a natural class B GPCR agonist","volume":"31","author":"Li","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.abb.2025.110470_bib35","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00394-017-1433-z","article-title":"Myricetin\u2010induced brown adipose tissue activation prevents obesity and insulin resistance in db\/db mice","volume":"57","author":"Hu","year":"2018","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.abb.2025.110470_bib36","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/ptr.5989","article-title":"Myricetin attenuated LPS induced cardiac injury in vivo and in vitro","volume":"32","author":"Zhang","year":"2018","journal-title":"Phytother Res."},{"key":"10.1016\/j.abb.2025.110470_bib37","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ejphar.2016.05.025","article-title":"Flavonoid myricetin inhibits TNF\u2010\u03b1\u2010stimulated production of inflammatory mediators by suppressing the Akt, mTOR and NF\u2010\u03baB pathways in human keratinocytes","volume":"784","author":"Lee","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.abb.2025.110470_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115323","article-title":"Anti\u2010HIV\u20101 activity of flavonoid myricetin on HIV\u20101 infection in a dual\u2010chamber in vitro model","volume":"9","author":"Pasetto","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.abb.2025.110470_bib39","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/j.bmcl.2011.12.145","article-title":"Small molecule inhibitors of the HPV16\u2010E6 interaction with caspase 8","volume":"22","author":"Yuan","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.abb.2025.110470_bib40","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3390\/nu8020090","article-title":"Myricetin: a dietary molecule with diverse biological activities","volume":"8","author":"Semwal","year":"2016","journal-title":"Nutrients"},{"issue":"10","key":"10.1016\/j.abb.2025.110470_bib41","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0955-2863(02)00208-5","article-title":"Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships","volume":"13","author":"Heim","year":"2002","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.abb.2025.110470_bib42","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s40495-021-00269-2","article-title":"Myricetin: a multifunctional flavonol in biomedicine","volume":"8","author":"Agraharam","year":"2022","journal-title":"Curr. Pharmacol. Rep."},{"issue":"Suppl 2","key":"10.1016\/j.abb.2025.110470_bib43","first-page":"S253","article-title":"Structure-affinity relationship of flavones on binding to serum albumins: effect of hydroxyl groups on ring A","volume":"54","author":"Xiao","year":"2010","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.abb.2025.110470_bib44","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11130-007-0047-7","article-title":"Estimation of daily human intake of food flavonoids","volume":"62","author":"Mullie","year":"2007","journal-title":"Plant Foods Hum. Nutr."},{"key":"10.1016\/j.abb.2025.110470_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/chin.199819287","article-title":"Structure\u2014antioxidant activity relationship of flavonoids and isoflavonoids","volume":"29","author":"Rice-Evans","year":"1998","journal-title":"ChemInform"},{"key":"10.1016\/j.abb.2025.110470_bib46","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.lfs.2018.06.006","article-title":"Myricetin ameliorates glucocorticoid\u2010induced osteoporosis through the ERK signalling pathway","volume":"207","author":"Fan","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.abb.2025.110470_bib47","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.ijbiomac.2019.11.075","article-title":"The hepatoprotective effect of myricetin against lipopolysaccharide and D\u2010galactosamine\u2010induced fulminant hepatitis","volume":"155","author":"Lv","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.abb.2025.110470_bib48","doi-asserted-by":"crossref","first-page":"5854","DOI":"10.1002\/fsn3.2513","article-title":"Myricetin: a comprehensive review on its biological potentials","volume":"9","author":"M","year":"2021","journal-title":"Food Sci. Nutr."},{"key":"10.1016\/j.abb.2025.110470_bib49","doi-asserted-by":"crossref","first-page":"6419","DOI":"10.1021\/bi5010365","article-title":"The newly discovered Parkinson's disease associated Finnish mutation (A53E) attenuates \u03b1-Synuclein aggregation and membrane binding","volume":"53","author":"Ghosh","year":"2014","journal-title":"Biochemistry"},{"key":"10.1016\/j.abb.2025.110470_bib50","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.colsurfb.2015.05.031","article-title":"Thermodynamic insights into drug-surfactant interactions: study of the interactions of naporxen, diclofenac sodium, neomycin, and lincomycin with hexadecytrimethylammonium bromide by using isothermal titration calorimetry","volume":"132","author":"Choudhary","year":"2015","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"1","key":"10.1016\/j.abb.2025.110470_bib51","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jmb.2005.07.075","article-title":"Structural basis of the drug-binding specificity of human serum albumin","volume":"353","author":"Ghuman","year":"2005","journal-title":"J. Mol. Biol."},{"issue":"2","key":"10.1016\/j.abb.2025.110470_bib52","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/protein\/8.2.127","article-title":"LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions","volume":"8","author":"Wallace","year":"1995","journal-title":"Protein Eng."},{"issue":"10","key":"10.1016\/j.abb.2025.110470_bib53","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1021\/ci200227u","article-title":"LigPlot+: multiple ligand-protein interaction diagrams for drug discovery","volume":"51","author":"Laskowski","year":"2011","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.abb.2025.110470_bib54","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.jmb.2008.11.006","article-title":"Molecular mechanism of thioflavin-T binding to the surface of beta-rich peptide self-assemblies","volume":"385","author":"Biancalana","year":"2009","journal-title":"J. Mol. Biol."},{"issue":"4","key":"10.1016\/j.abb.2025.110470_bib55","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s12551-016-0218-6","article-title":"Dynamic light scattering: a practical guide and applications in biomedical sciences","volume":"8","author":"Stetefeld","year":"2016","journal-title":"Biophys Rev"},{"key":"10.1016\/j.abb.2025.110470_bib56","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.3390\/ijms21145061","article-title":"Role of tyr-39 for the structural features of \u03b1-synuclein and for the interaction with a strong modulator of its amyloid assembly","volume":"21","author":"Palomino-Hernandez","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.abb.2025.110470_bib57","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/nbt.1990","article-title":"Comprehensive analysis of kinase inhibitor selectivity","volume":"29","author":"Davis","year":"2011","journal-title":"Nat. Biotechnol."},{"issue":"23","key":"10.1016\/j.abb.2025.110470_bib58","doi-asserted-by":"crossref","first-page":"7203","DOI":"10.1021\/acs.langmuir.1c00773","article-title":"Correlating the properties of antibiotics with the energetics of partitioning in colloidal self-assemblies and the effect on the binding of a released drug with a target protein","volume":"37","author":"Judy","year":"2021","journal-title":"Langmuir"},{"key":"10.1016\/j.abb.2025.110470_bib59","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jct.2016.08.020","article-title":"Binding thermodynamics of Diclofenac and Naproxen with human and bovine serum albumins: a calorimetric and spectroscopic study","volume":"103","author":"Fadi","year":"2016","journal-title":"J. Chem. Thermodyn."},{"key":"10.1016\/j.abb.2025.110470_bib60","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.ijbiomac.2021.05.071","article-title":"Modulation of \u03b1-synuclein fibrillation by plant metabolites, daidzein, fisetin and scopoletin under physiological conditions","volume":"182","author":"Rane","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"issue":"W1","key":"10.1016\/j.abb.2025.110470_bib61","doi-asserted-by":"crossref","first-page":"W159","DOI":"10.1093\/nar\/gkac394","article-title":"CB-Dock2: improved protein-ligand blind docking by integrating cavity detection, docking and homologous template fitting","volume":"50","author":"Liu","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.abb.2025.110470_bib62","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbac087","article-title":"FitDock: protein-ligand docking by template fitting","volume":"23","author":"Yang","year":"2022","journal-title":"Briefings Bioinf."},{"issue":"1","key":"10.1016\/j.abb.2025.110470_bib63","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/s41401-019-0228-6","article-title":"CB-Dock: a web server for cavity detection-guided protein-ligand blind docking","volume":"41","author":"Liu","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"issue":"12","key":"10.1016\/j.abb.2025.110470_bib64","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1093\/bioinformatics\/btu104","article-title":"Bioinformatics, Improved protein-ligand binding affinity prediction by using a curvature-dependent surface-area model","volume":"30","author":"Cao","year":"2014","journal-title":"Bioinformatics (Edam)"},{"issue":"5","key":"10.1016\/j.abb.2025.110470_bib65","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nsmb.3194","article-title":"Solid-state NMR structure of a pathogenic fibril of full-length human \u03b1-synuclein","volume":"23","author":"Tuttle","year":"2016","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"11","key":"10.1016\/j.abb.2025.110470_bib66","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/3311","article-title":"Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease","volume":"4","author":"Conway","year":"1998","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.abb.2025.110470_bib67","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1073\/pnas.0407146102","article-title":"Release of long-range tertiary interactions potentiates aggregation of natively unstructured alpha-synuclein","volume":"102","author":"Bertoncini","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"16","key":"10.1016\/j.abb.2025.110470_bib68","doi-asserted-by":"crossref","first-page":"9443","DOI":"10.1074\/jbc.273.16.9443","article-title":"Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes","volume":"273","author":"Davidson","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.abb.2025.110470_bib69","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.3390\/cells11111732","article-title":"Alpha-synuclein aggregation pathway in Parkinson's disease: current status and novel therapeutic approaches","volume":"11","author":"Vidovi\u0107","year":"2022","journal-title":"Cell"}],"container-title":["Archives of Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986125001833?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986125001833?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T04:29:10Z","timestamp":1778646550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003986125001833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":69,"alternative-id":["S0003986125001833"],"URL":"https:\/\/doi.org\/10.1016\/j.abb.2025.110470","relation":{},"ISSN":["0003-9861"],"issn-type":[{"value":"0003-9861","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanism of flavonoid myricetin modulated aggregation in \u03b1-Synuclein and its familial mutants E46K and A30P","name":"articletitle","label":"Article Title"},{"value":"Archives of Biochemistry and Biophysics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abb.2025.110470","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110470"}}